Collaborate on access to Darunavir for India

Tibotec Pharmaceuticals has signed a royalty-free, non-exclusive license agreement with Emcure Pharmaceuticals Limited of India to distribute the Protease Inhibitor Darunavir (DRV) in India.

Tibotec has collaborated with Emcure because of the company’s strong reputation in India and extensive reach through its country-wide distribution network. The agreement will help to build a sustainable effort in India to ensure patients in need have access to Darunavir (DRV)